4 Results for "

BRD4-IN-10

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "BRD4-IN-10" in MCE Product Catalog:

Cat. No.: HY-174348
CAS No.: 3051852-76-4
Research Areas:  

Inflammation/Immunology

BRD4-IN-10 (Compound 31) is a selective BRD4 inhibitor with an IC50 of 13.5 nM. BRD4-IN-10 can exert anti-inflammatory and anti-fibrotic effects. BRD4-IN-10 also has good metabolic stability, pharmacokinetic properties and safety. BRD4-IN-10 can be used in the research of renal fibrosis diseases .
loading...
    loading...
Cat. No.: HY-117491
CAS No.: 1660117-38-3
Purity:  99.52%
Research Areas:  

Cancer

BRD4 Inhibitor-10 is a potent BRD4-BD1 inhibitor with an IC50 of 8 nM. BRD4 Inhibitor-10 interferes with the recognition of acetylated histone marks by the BRD4 bromodomain through inhibiting the interaction between BRD4-BD1 and tetra-acetylated histone H4 peptide. BRD4 Inhibitor-10 is used for research on BRD4-mediated epigenetic regulation and cancer .
loading...
    loading...
Cat. No.: HY-185884
CAS No.: 2086299-38-7
BRD4 ligand 10 is a PROTAC target protein ligand. BRD4 ligand 10 can be used to synthesize PROTAC BRD4 Degrader-49 (HY-185854).
loading...
    loading...
Cat. No.: HY-187390
BRD4 RIMTAC-1 is a BRD4 PROTAC degrader based on the RIPK1-mediated targeted chimera (RIMTAC) technology. It hijacks the endogenous RIPK1-VHL complex via the RIPK1 inhibitor moiety to indirectly recruit the VHL E3 ligase, forming a BRD4-Compound 10-RIPK1-VHL quaternary complex, and degrades BRD4 through the ubiquitin-proteasome system (UPS). BRD4 RIMTAC-1 exhibits selectivity over other BET proteins, induces concentration- and time-dependent, reversible post-translational degradation of BRD4 without altering the target mRNA level. BRD4 RIMTAC-1 potently induces endogenous BRD4 degradation in RAW264.7 and HEK-293T cells, with DC50 values of 179.1 nM and 54.12 nM, respectively. BRD4 RIMTAC-1 can be used for the research of cancer and inflammation-related diseases .
loading...
    loading...